Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Quick Specs Form: Lyophilized powder (white to off-white) Purity: 99% by HPLC every batch Identity: MS molecular-weight confirmed every batch CAS Number: 2381089-83-2 Also Known As: LY3437943, triple incretin agonist Sequence Length: 39 amino acids Molecular Formula: C228H350N48O66 (confirm per COA) Molecular Weight: ~4731 Da (confirm per COA) Receptor Targets: GIPR + GLP-1R + GCGR Modification: Fatty-diacid side chain (albumin binding) Half-Life: ~6 days (research literature) Peptide Type: Synthetic triple incretin receptor agonist COA: Janoshik third-party publicly verifiable Manufacture: Lyophilized & QC-released in-house Storage: 20C sealed | 28C reconstituted Shelf Life: 24 months unopened (lyophilized) Certificate of Analysis Janoshik ThirdParty Verification Every batch is independently tested by Janoshik
Adult Obesity Prevalence Maps
SGLT2i exert a complex cardioprotective mechanism independent from their antihyperglycemic effects
A medical practitioner will provide personalized recommendations
(17) Costs concerns Commercial Insurance Semaglutide injections, on average, can cost between $900-$2000+ per month for patients without insurance
Yelena Dokic, MD, is a dermatology resident at the Baylor College of Medicine
